首页> 外文期刊>Clinical and experimental metastasis >Enhancement of metastatic ability by ectopic expression of ST6GalNAcI on a gastric cancer cell line in a mouse model
【24h】

Enhancement of metastatic ability by ectopic expression of ST6GalNAcI on a gastric cancer cell line in a mouse model

机译:通过在小鼠模型中异位表达ST6GalNAcI在胃癌细胞系上增强转移能力

获取原文
获取原文并翻译 | 示例
           

摘要

ST6GalNAcI is a sialyltransferase responsible for the synthesis of sialyl Tn (sTn) antigen which is expressed in a variety of adenocarcinomas including gastric cancer especially in advanced cases, but the roles of ST6GalNAcI and sTn in cancer progression are largely unknown. We generated sTn-expressing human gastric cancer cells by ectopic expression of ST6GalNAcI to evaluate metastatic ability of these cells and prognostic effect of ST6GalNAcI and sTn in a mouse model, and identified sTn carrier proteins to gain insight into the function of ST6GalNAcI and sTn in gastric cancer progression. A green fluorescent protein-tagged human gastric cancer cell line was transfected with ST6GalNAcI to produce sTn-expressing cells, which were transplanted into nude mice. STn-positive gastric cancer cells showed higher intraperitoneal metastatic ability in comparison with sTn-negative control, resulting in shortened survival time of the mice, which was mitigated by anti-sTn antibody administration. Then, sTn-carrying proteins were immunoprecipitated from culture supernatants and lysates of these cells, and identified MUC1 and CD44 as major sTn carriers. It was confirmed that MUC1 carries sTn also in human advanced gastric cancer tissues. Identification of sTn carrier proteins will help understand mechanisms of metastatic phenotype acquisition of gastric cancer cells by ST6GalNAcI and sTn.
机译:ST6GalNAcI是负责合成唾液酸Tn(sTn)抗原的唾液酸转移酶,它在包括胃癌在内的多种腺癌中表达,尤其是在晚期病例中,但是在癌症进展中,ST6GalNAcI和sTn的作用尚不清楚。我们通过异位表达ST6GalNAcI产生了表达sTn的人胃癌细胞,以评估这些细胞的转移能力以及ST6GalNAcI和sTn在小鼠模型中的预后效果,并鉴定了sTn载体蛋白以深入了解胃中ST6GalNAcI和sTn的功能癌症进展。用ST6GalNAcI转染带有绿色荧光蛋白标签的人胃癌细胞系,以产生表达sTn的细胞,然后将其移植到裸鼠中。与sTn阴性对照相比,STn阳性胃癌细胞显示出更高的腹膜内转移能力,从而缩短了小鼠的存活时间,这可通过给予抗sTn抗体来缓解。然后,从培养上清液和这些细胞的裂解物中免疫沉淀携带sTn的蛋白质,并确定MUC1和CD44是主要的sTn载体。证实了MUC1在人的晚期胃癌组织中也携带sTn。 sTn载体蛋白的鉴定将有助于了解ST6GalNAcI和sTn对胃癌细胞转移表型的获取机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号